Controversies in the management of ESBL-producing Enterabacterales. Clinical Implications.

Rev Esp Quimioter · 2022 · PMC9717462 · PMID 36285857

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Thirty-day mortality was 10% and 19% in the empiric cohort and 9% and 17% in the definitive cohort for BLBLIs and carbapenems, respectively, although these differences did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.